SNDX
Syndax Pharmaceuticals Inc
NASDAQ · Healthcare · Biotechnology · US
$10.48
−26.66%Leverage
- Debt / equity
- -34.31x
- Net debt / equity
- -26.40x
- Debt / assets
- 0.85x
- Debt / EBITDA
- -4.94x
- Net debt / EBITDA
- -3.80x
Liquidity & coverage
- Current ratio
- 4.69x
- Quick ratio
- 4.37x
- Cash ratio
- 3.53x
- Interest coverage
- -1.98x
- EBITDA / interest
- -1.32x
- Working capital
- $446.5M
Cash & dividend
- FCF / debt
- -0.30x
- Cash flow / debt
- -0.30x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026